前瞻性观察研究：评估口服 AHCC 和 Crispatus M247 乳酸菌补充剂对 HPV 清除和低级别鳞状上皮内病变消退的影响

Annals of Research in Oncology Pub Date : 2024-03-01 DOI:10.48286/aro.2024.83

Vincenzino Salimbeni, Canio Martinelli, Lavinia Porto, M. Donne, Angela Alibrandi, Francesco Di Pierro, Flaviana Cau, R. Granese, Vito Iannone, Liliana Marchetta, Alfredo Ercoli, Combining Ahcc, L. Crispatus

{"title":"前瞻性观察研究：评估口服 AHCC 和 Crispatus M247 乳酸菌补充剂对 HPV 清除和低级别鳞状上皮内病变消退的影响","authors":"Vincenzino Salimbeni, Canio Martinelli, Lavinia Porto, M. Donne, Angela Alibrandi, Francesco Di Pierro, Flaviana Cau, R. Granese, Vito Iannone, Liliana Marchetta, Alfredo Ercoli, Combining Ahcc, L. Crispatus","doi":"10.48286/aro.2024.83","DOIUrl":null,"url":null,"abstract":": Human papillomavirus (HPV), especially high-risk types like HPV 16 and 18, can progress from low-grade lesions (LSIL) to cancer. While HR-HPV and LSIL often regress naturally, some cases may advance to malignancy. Current treatments vary in efficacy and can have adverse effects. Emerging research on Lactobacillus Crispatus M247 and Active Hexose Correlated Compound (AHCC) shows potential for enhancing HPV clearance and LSIL regression with minimal side effects. However, the precise impact of these treatments remains under study","PeriodicalId":148778,"journal":{"name":"Annals of Research in Oncology","volume":"13 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A prospective observational study to evaluate impact of oral supplementation with AHCC and Lactobacillus Crispatus M247 on HPV clearance and low-grade squamous intraepithelial lesion regression\",\"authors\":\"Vincenzino Salimbeni, Canio Martinelli, Lavinia Porto, M. Donne, Angela Alibrandi, Francesco Di Pierro, Flaviana Cau, R. Granese, Vito Iannone, Liliana Marchetta, Alfredo Ercoli, Combining Ahcc, L. Crispatus\",\"doi\":\"10.48286/aro.2024.83\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": Human papillomavirus (HPV), especially high-risk types like HPV 16 and 18, can progress from low-grade lesions (LSIL) to cancer. While HR-HPV and LSIL often regress naturally, some cases may advance to malignancy. Current treatments vary in efficacy and can have adverse effects. Emerging research on Lactobacillus Crispatus M247 and Active Hexose Correlated Compound (AHCC) shows potential for enhancing HPV clearance and LSIL regression with minimal side effects. However, the precise impact of these treatments remains under study\",\"PeriodicalId\":148778,\"journal\":{\"name\":\"Annals of Research in Oncology\",\"volume\":\"13 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Research in Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48286/aro.2024.83\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Research in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48286/aro.2024.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

:人类乳头瘤病毒（HPV），尤其是 HPV 16 和 18 等高危型 HPV，可从低级别病变（LSIL）发展为癌症。虽然HR-HPV和LSIL通常会自然消退，但有些病例可能会发展为恶性肿瘤。目前的治疗方法疗效不一，并可能产生不良影响。有关 Crispatus M247 乳杆菌和活性己糖相关化合物（AHCC）的最新研究显示，这些药物有可能在副作用最小的情况下提高清除 HPV 和 LSIL 的能力。然而，这些疗法的确切影响仍在研究之中

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

A prospective observational study to evaluate impact of oral supplementation with AHCC and Lactobacillus Crispatus M247 on HPV clearance and low-grade squamous intraepithelial lesion regression

: Human papillomavirus (HPV), especially high-risk types like HPV 16 and 18, can progress from low-grade lesions (LSIL) to cancer. While HR-HPV and LSIL often regress naturally, some cases may advance to malignancy. Current treatments vary in efficacy and can have adverse effects. Emerging research on Lactobacillus Crispatus M247 and Active Hexose Correlated Compound (AHCC) shows potential for enhancing HPV clearance and LSIL regression with minimal side effects. However, the precise impact of these treatments remains under study

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of Research in Oncology

自引率

0.00%

发文量